tiprankstipranks
Company Announcements

Renalytix to Revert to Foreign Private Issuer Status

Story Highlights
Renalytix to Revert to Foreign Private Issuer Status

An announcement from Renalytix ( (RNLXY) ) is now available.

Renalytix plc announced it will transition back to filing as a foreign private issuer (FPI) with the Securities and Exchange Commission effective January 1, 2025. The company had been filing as a domestic reporting company since July 1, 2023 but determined it qualified as an FPI as of December 31, 2024, adhering to the guidelines set by the Securities Act of 1933.

More about Renalytix

YTD Price Performance: 23.81%

Average Trading Volume: 80,480

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $48.6M

See more insights into RNLXY stock on TipRanks’ Stock Analysis page.

Questions or Comments about the article? Write to editor@tipranks.com

Questions or Comments about the article? Write to editor@tipranks.com
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App